Russia permanently registers Favipiravir for Covid treatment

Desk Report, sukhabor.com: Favipiravir, a drug used to treat COVID-19, has received permanent registration in Russia, Russian Deputy Health Minister Viktor Fisenko said on Thursday, reports TASS.

No serious side effects of favipiravir recorded in Russia, Healthcare Ministry says.

“Following a sped-up procedure, we have greenlit circulation of prevention drugs (vaccines), antiviral therapy drugs – Favipiravir, Remdesivir, and a drug used to mitigate a cytokine storm – Levilimab,” he said, adding that Favipiravir has received a permanent registration certificate.

Earlier, the Russian Federal Service for Surveillance in Healthcare informed that Russia had registered three drugs based on Favipiravir: Avifavir, Areplivir and Coronavirus.

The watchdog has not received any complaints of non-specific motor disorders during the use of the drugs.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

MOST POPULAR

RECENT COMMENTS